Serum levels of N-acetylaspartate in Huntington's disease: Preliminary results

Movement Disorders

Volumn 27, Issue 2, 2012, Pages 329-330

  Ruggieri, Maddalena ^a   Serpino, Claudia ^a   Ceci, Edmondo ^a   Sciruicchio, Vittorio ^a   Franco, Giovanni ^a   Pica, Carmela ^a   Trojano, Maria ^a   Livrea, Paolo ^a   de Tommaso, Marina ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLOTIAPINE; N ACETYLASPARTIC ACID; QUETIAPINE; RISPERIDONE; TETRABENAZINE;

ADULT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUNTINGTON CHOREA; LETTER; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT; PRIORITY JOURNAL; TOTAL FUNCTIONAL CAPACITY SCALE; UNIFIED PARKINSON DISEASE RATING SCALE;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 84856967817     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23974     Document Type: Letter

References (7)

1. Sturrock A, Laule C, Decolongon J, et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 2010; 75: 1702-1710.
2. Teunissen CE, Iacobaeu E, Khademi M, et al. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009; 72: 1322-1329.
3. Ruggieri M, Tortorella C, Ceci E, et al. Age-related changes of serum N-acetyl-aspartate in healthy controls. Age Ageing 2011; 40: 391-395.
4. Tortorella C, Ruggieri M, Di Monte E, et al. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 2011 May 27; [Epub ahead of print].
5. Simone IL, Ruggieri M, Tortelli T, et al. Serum N-acetyl-aspartate in amyotrophic lateral sclerosis. Arch Neurol (in press).
6. Huntington Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
7. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009; 8: 791-801.